Valuation: PetIQ, Inc.

Market Cap 919M 804M 738M 688M 1.31B 87.52B 1.33B 8.87B 3.45B 43.02B 3.45B 3.38B 148B P/E 2022
-5.58x
P/E 2023 282x
Enterprise Value 1.27B 1.11B 1.02B 952M 1.81B 121B 1.83B 12.26B 4.77B 59.49B 4.77B 4.67B 205B EV / Sales 2022
0.69x
EV / Sales 2023 0.84x
Free-Float
91.62%
Yield 2022 *
-
Yield 2023 -
3 years 14.2
Extreme 14.2
31.06
5 years 6.66
Extreme 6.66
39.08
10 years 6.66
Extreme 6.66
46
Manager TitleAgeSince
Chief Executive Officer 55 2025-02-16
Director of Finance/CFO 62 2022-01-02
President 48 2022-05-31
Director TitleAgeSince
Director/Board Member 70 2024-10-24
Director/Board Member - 2024-10-24
Director/Board Member - 2024-10-24
Date Insider Type Main position Quantity % Market Cap.
24-10-24
Eos Management LP
Issuer saleCompany 1,972,687 6.6488%
24-10-24Issuer sale

Director

18,925 0.0638%
24-10-24Issuer sale

Director

16,910 0.0570%
Change 5-day change 1-year change 3-year change Capi.($)
-0.03%-.--%-.--%+102.75% 919M
+3.24%-1.70%-53.01%-56.06% 31.36B
+3.78%+1.75%+70.77%+149.25% 12.49B
+1.56%-4.08%-13.04%+5.09% 3.84B
+0.15%-2.92%-3.91%+22.51% 3.18B
+2.93%+7.60%+53.68%+27.83% 1.98B
+0.50%+2.89%-27.86%+18.36% 1.66B
+3.61%+4.95%+18.79%+141.72% 1.35B
+2.74%+9.39%-20.52%-11.63% 1.05B
-1.39%-2.21%-6.23%-23.04% 941M
Average +1.71%+1.72%+1.87%+37.68% 5.88B
Weighted average by Cap. +2.86%-0.87%-13.33%+9.09%

Financials

2022 2023
Net sales 922M 806M 740M 690M 1.31B 87.74B 1.33B 8.89B 3.46B 43.13B 3.46B 3.38B 149B 1.1B 963M 885M 825M 1.57B 105B 1.59B 10.63B 4.13B 51.57B 4.14B 4.05B 178B
Net income -48.21M -42.14M -38.73M -36.1M -68.47M -4.59B -69.51M -465M -181M -2.26B -181M -177M -7.77B 2.13M 1.86M 1.71M 1.6M 3.03M 203M 3.07M 20.55M 7.99M 99.74M 8M 7.83M 344M
Net Debt 371M 324M 298M 278M 526M 35.29B 534M 3.58B 1.39B 17.35B 1.39B 1.36B 59.78B 352M 308M 283M 264M 500M 33.51B 507M 3.39B 1.32B 16.47B 1.32B 1.29B 56.76B
Logo PetIQ, Inc.
PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company operates through two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to major United States retail and e-commerce channels through more than 60,000 points of distribution. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 39 states. The segment’s services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks. The Rx pet medications products include flea and tick control, heartworm preventatives, arthritis, thyroid, and other specialty medications.
Employees
1,527
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. PETQ Stock